Catherine Baize

Lab Manager/Phlebotomist
A bespectacled, young white woman with long brown hair all the way up to her elbows


  • Cardio-Phlebotomy Technician – Medcerts Online Training


  • Phlebotomist and Lab Manager – Research Integrity, LLC
  • Phlebotomist – Plasma Biological Services

Training & Qualifications

  • IATA: computer training; current certificate holder
  • GCP CITI: Collaborative Institutional Training Initiative
  • Attends Investigator’s Meetings (since 2021)
  • Assists the PI in delegated duties (Since 2021)
  • Vitals
  • Blood Draws
  • Venipuncture

Clinical Research

  • A 12 week, phase 2A, randomized, double-blind, sponsor-open, placebo-controlled, parallel group study to assess the safety, tolerability and pharmacodynamics of PF-06882961 titration in adults with type 2 diabetes mellitus treated with meltformin and in non-diabetic adults with obesity C3421008
  • A Phase 3, double-blind, randomized placebo-controlled, Multicenter Study of the Efficacy and Safety of Tolperisone in Subjects with Pain due to Acute Back Muscle Spasm Neurana
  • Traverse – Testosterone replacement therapy for assessment of long-term vascular events and efficacy response in hypogonadal men. ABBVIE M16-100
  • Prospective US Radiofrequency SUI Trial (Viveve/ Pursuit)
  • A Phase 3 randomized, double-blind, placebo-controlled, multi-center study in adults to determine the safety and efficacy of AZD7442, a combination product of two monoclonal antibodies (AZD8895 and AZD1061), for post-exposure prophylaxis of Covid-19 (D8850C00003)